BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36922710)

  • 21. Functional polymorphisms of circadian negative feedback regulation genes are associated with clinical outcome in hepatocellular carcinoma patients receiving radical resection.
    Zhang Z; Ma F; Zhou F; Chen Y; Wang X; Zhang H; Zhu Y; Bi J; Zhang Y
    Med Oncol; 2014 Dec; 31(12):179. PubMed ID: 25344870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
    Ma X; Ding Y; Zeng L
    BMC Cancer; 2021 Apr; 21(1):418. PubMed ID: 33858382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Cao L; Cheng H; Jiang Q; Li H; Wu Z
    Aging (Albany NY); 2020 Mar; 12(5):4573-4591. PubMed ID: 32167932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies.
    Harding JJ; Nandakumar S; Armenia J; Khalil DN; Albano M; Ly M; Shia J; Hechtman JF; Kundra R; El Dika I; Do RK; Sun Y; Kingham TP; D'Angelica MI; Berger MF; Hyman DM; Jarnagin W; Klimstra DS; Janjigian YY; Solit DB; Schultz N; Abou-Alfa GK
    Clin Cancer Res; 2019 Apr; 25(7):2116-2126. PubMed ID: 30373752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rs2303428 of MSH2 Is Associated with Hepatocellular Carcinoma Prognosis in a Chinese Population.
    Zhu X; Wang Z; Qiu X; Wang W; Bei C; Tan C; Qin L; Ren Y; Tan S
    DNA Cell Biol; 2018 Jul; 37(7):634-641. PubMed ID: 29874113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma.
    Xu QG; Yuan SX; Tao QF; Yu J; Cai J; Yang Y; Guo XG; Lin KY; Ma JZ; Dai DS; Wang ZG; Gu FM; Zhao LH; Li LQ; Liu JF; Sun SH; Zang YJ; Liu H; Yang F; Zhou WP
    J Hepatol; 2019 May; 70(5):904-917. PubMed ID: 30654066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy.
    Hu W; Huang S; Dong L; Yu C; Li C; Zhang J
    Anticancer Drugs; 2019 Mar; 30(3):233-240. PubMed ID: 30779721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.
    Yin F; Shu L; Liu X; Li T; Peng T; Nan Y; Li S; Zeng X; Qiu X
    J Exp Clin Cancer Res; 2016 Aug; 35(1):127. PubMed ID: 27567667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients.
    Zhang H; Guo X; Dai J; Wu Y; Ge N; Yang Y; Ji J; Zhang H
    Med Oncol; 2014 Nov; 31(11):278. PubMed ID: 25355558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A predictive and prognostic model for hepatocellular carcinoma with microvascular invasion based TCGA database genomics.
    Wang J; Ding ZW; Chen K; Liu YZ; Li N; Hu MG
    BMC Cancer; 2021 Dec; 21(1):1337. PubMed ID: 34911488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non‑coding RNA‑based risk scoring system predicts prognosis of alcohol‑related hepatocellular carcinoma.
    Luo Y; Ye J; Wei J; Zhang J; Li Y
    Mol Med Rep; 2020 Aug; 22(2):997-1007. PubMed ID: 32468063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.
    Fiorino S; Bacchi-Reggiani ML; Visani M; Acquaviva G; Fornelli A; Masetti M; Tura A; Grizzi F; Zanello M; Mastrangelo L; Lombardi R; Di Tommaso L; Bondi A; Sabbatani S; Domanico A; Fabbri C; Leandri P; Pession A; Jovine E; de Biase D
    World J Gastroenterol; 2016 Apr; 22(15):3907-36. PubMed ID: 27099435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Goldani F; Parizadeh SMR; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Avan A
    Curr Drug Targets; 2019; 20(11):1129-1140. PubMed ID: 30848198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
    Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
    Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Yang Y; Xia T; Li N; Zhang J; Yang Y; Cong W; Deng Q; Lan K; Zhou W
    Protein Cell; 2013 Jan; 4(1):71-81. PubMed ID: 23292895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a prognostic model for hepatocellular carcinoma using genes involved in aerobic respiration.
    Rao J; Wu X; Zhou X; Deng R; Ma Y
    Aging (Albany NY); 2021 Apr; 13(9):13318-13332. PubMed ID: 33903282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma.
    Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges of incorporating gene expression data to predict HCC prognosis in the age of systems biology.
    Du Y; Cao GW
    World J Gastroenterol; 2012 Aug; 18(30):3941-4. PubMed ID: 22912544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in molecular biomarkers for patients with hepatocellular carcinoma.
    Umeda S; Kanda M; Kodera Y
    Expert Rev Mol Diagn; 2019 Aug; 19(8):725-738. PubMed ID: 31248309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.